AlveoliX AG

About

AlveoliX AG is a Swiss biotechnology company specializing in the development and commercialization of organs-on-chip platforms that accurately recreate the microenvironment of human tissues. Their main focus is on lung-on-chip technology, which simulates breathing mechanics and physiological conditions to provide more predictive and translational models for drug discovery, disease modeling, and safety testing. The company's mission is to make organs-on-chip the new standard for preclinical decision-making, aiming to reduce animal testing and accelerate drug development by providing better, safer, and more personalized data from bench to clinic.